Filing Details

Accession Number:
0001133416-24-000040
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-04-25 13:27:10
Reporting Period:
2024-04-24
Accepted Time:
2024-04-25 13:27:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1133416 Galectin Therapeutics Inc GALT Pharmaceutical Preparations (2834) 043562325
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1725595 Joel Lewis C/O Galectin Therapeutics Inc.
4960 Peachtree Industrial Blvd., Ste 240
Norcross GA 30071
President And Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-04-24 1,000 $3.39 2,000 No 4 P Indirect as UTMA custodian for a minor child
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect as UTMA custodian for a minor child
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 897,012 Direct
Footnotes
  1. Represents average price in multiple transactions with low of $3.30 per share and high of $3.41 per share
  2. These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose.